Geisinger launched its ProvenRecovery pilot in June 2017, which aimed to speed up recovery time, improve pain management and decrease opioid use among certain surgery patients. Geisinger said Nov. 15 it will extend the program to 42 surgical procedures affecting about 15,000 surgery cases each year. The system expects ProvenRecovery to reach 100 surgical specialties by the end of 2019.
The ProvenRecovery pilot led to an 18 percent decrease in opioid use across the health system. Patients who underwent neurosurgery and colorectal surgery saw their hospital stays cut in half. For colorectal surgery patients in particular, earlier discharges resulted in an average savings of $4,556 per case.
“In my 35 years in surgery, this is the innovation with the greatest potential to improve the patient experience, save lives, reduce complications and be less disruptive to patients,” Neil Martin, MD, Geisinger’s chief quality officer and chair of Geisinger’s neuroscience institute, said in a news release. “With ProvenRecovery, we are empowering patients to be healthier before surgery, leading to fewer surgical complications and patients returning to their lives sooner.”
More articles on quality:
11th child dies in New Jersey adenovirus outbreak
Consumer Reports urges USDA to name turkey brands in salmonella outbreak as Thanksgiving nears
CDC investigating string of new polio-like paralysis cases in children
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.